A recent report, proposing the function of cytoplasmic NIS as an element of a pathway involved in tumor cell invasive capacity[76], suggests a role of cytoplasmic NIS in tumor aggressiveness, strengthening the hypothesis of using NIS expression as biomarker for defining individuals with biologically active prostate cancer. Here, SLC5A5 is linked to prostate carcinoma.